These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 16025528)

  • 1. In vitro reactivation potency of some acetylcholinesterase reactivators against sarin- and cyclosarin-induced inhibitions.
    Kuca K; Cabal J; Jun D; Kassa J; Bartosová L; Kunesová G
    J Appl Toxicol; 2005; 25(4):296-300. PubMed ID: 16025528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the potency of newly developed oximes (K005, K027, K033, K048) and currently used oximes (pralidoxime, obidoxime, HI-6) to reactivate sarin-inhibited rat brain acetylcholinesterase by in vitro methods.
    Kuca K; Cabal J; Kassa J
    J Toxicol Environ Health A; 2005 Apr; 68(8):677-86. PubMed ID: 15901095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the efficacy of a bispyridinium oxime--1,4-bis-(2-hydroxyiminomethylpyridinium) butane dibromide and currently used oximes to reactivate sarin, tabun or cyclosarin-inhibited acetylcholinesterase by in vitro methods.
    Kuca K; Cabal J; Kassa J
    Pharmazie; 2004 Oct; 59(10):795-8. PubMed ID: 15544060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of nine oximes on in vivo reactivation of blood, brain, and tissue cholinesterase activity inhibited by organophosphorus nerve agents at lethal dose.
    Shih TM; Skovira JW; O'Donnell JC; McDonough JH
    Toxicol Mech Methods; 2009 Sep; 19(6-7):386-400. PubMed ID: 19778239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Currently used cholinesterase reactivators against nerve agent intoxication: comparison of their effectivity in vitro.
    Kuca K; Jun D; Bajgar J
    Drug Chem Toxicol; 2007; 30(1):31-40. PubMed ID: 17364862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A comparison of the efficacy of the reactivators of acetylcholinesterase inhibited with tabun].
    Cabal J; Kuca K; Jun D; Bajgar J; Hrabinová M
    Ceska Slov Farm; 2005 Jul; 54(4):192-5. PubMed ID: 16124202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of pentylsarin analogues with human acetylcholinesterase: a kinetic study.
    Worek F; Herkert NM; Koller M; Aurbek N; Thiermann H
    Toxicol Lett; 2009 Jun; 187(2):119-23. PubMed ID: 19429253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the potency of the oxime HLö-7 and currently used oximes (HI-6, pralidoxime, obidoxime) to reactivate nerve agent-inhibited rat brain acetylcholinesterase by in vitro methods.
    Kuca K; Cabal J; Kassa J; Jun D; Hrabinová M
    Acta Medica (Hradec Kralove); 2005; 48(2):81-6. PubMed ID: 16259317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of in vitro potency of oximes (pralidoxime, obidoxime, HI-6) to reactivate sarin-inhibited acetylcholinesterase in various parts of pig brain.
    Kuca K; Cabal J; Kassa J; Jun D; Hrabinová M
    J Appl Toxicol; 2005; 25(4):271-6. PubMed ID: 16021679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An evaluation of reactivating and therapeutic efficacy of newly developed oximes (K206, K269) and commonly used oximes (obidoxime, HI-6) in cyclosarin-poisoned rats and mice.
    Kassa J; Karasova J; Musilek K; Kuca K; Bajgar J
    Clin Toxicol (Phila); 2009 Jan; 47(1):72-6. PubMed ID: 18686075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro evaluation of bis-pyridinium oximes bearing methoxy alkane linker as reactivators of sarin inhibited human acetylcholinesterase.
    Acharya J; Dubey DK; Raza SK
    Toxicol In Vitro; 2010 Sep; 24(6):1797-802. PubMed ID: 20600799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective bisquaternary reactivators of tabun-inhibited AChE.
    Kuca K; Cabal J; Musilek K; Jun D; Bajgar J
    J Appl Toxicol; 2005; 25(6):491-5. PubMed ID: 16092078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potency of novel oximes to reactivate sarin inhibited human cholinesterases.
    Jun D; Kuca K; Picha J; Koleckar V; Marek J
    Drug Chem Toxicol; 2008; 31(1):1-9. PubMed ID: 18161504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bispyridinium oximes as antidotal treatment of cyclosarin poisoning-in vitro and in vivo testing.
    Bartosova L; Kuca K; Jun D; Kunesova G
    Int J Toxicol; 2005; 24(6):399-402. PubMed ID: 16393932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potency of five structurally different acetylcholinesterase reactivators to reactivate human brain cholinesterases inhibited by cyclosarin.
    Kuca K; Cabal J; Jun D; Hrabinova M
    Clin Toxicol (Phila); 2007; 45(5):512-5. PubMed ID: 17503257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A common mechanism for resistance to oxime reactivation of acetylcholinesterase inhibited by organophosphorus compounds.
    Maxwell DM; Brecht KM; Sweeney RE
    Chem Biol Interact; 2013 Mar; 203(1):72-6. PubMed ID: 22982773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potency of several oximes to reactivate human acetylcholinesterase and butyrylcholinesterase inhibited by paraoxon in vitro.
    Jun D; Musilova L; Kuca K; Kassa J; Bajgar J
    Chem Biol Interact; 2008 Sep; 175(1-3):421-4. PubMed ID: 18617161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactivation potency of new group of acetylcholinesterase reactivators and their comparison with currently available oximes.
    Kuca K; Pícha J; Jun D
    Acta Medica (Hradec Kralove); 2006; 49(4):233-5. PubMed ID: 17438836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzyme-kinetic investigation of different sarin analogues reacting with human acetylcholinesterase and butyrylcholinesterase.
    Bartling A; Worek F; Szinicz L; Thiermann H
    Toxicology; 2007 Apr; 233(1-3):166-72. PubMed ID: 16904809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactivation of organophosphate-inhibited human, Cynomolgus monkey, swine and guinea pig acetylcholinesterase by MMB-4: a modified kinetic approach.
    Worek F; Wille T; Aurbek N; Eyer P; Thiermann H
    Toxicol Appl Pharmacol; 2010 Dec; 249(3):231-7. PubMed ID: 20888357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.